Ascendis Pharma A/S
Ascendis Pharma A/S (ASND) Option Chain
As of September 25, 2026, Ascendis Pharma A/S is trading at $225.60, a -2.22% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 41.3%. IV Rank is 21%.
Read more
Tracking the ASND option chain helps you see every strike and expiry on Ascendis Pharma A/S in one view, so you can quickly identify the contracts that fit your thesis and your risk. Ascendis Pharma A/S's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ASND options activity at a glance. Use our scanner to monitor the ASND option chain in real time and filter for the ASND options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ASND stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ASND option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ASND stock options are being actively traded and where they are not.
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Ascendis Pharma A/S's full chain across every expiry, highlights the most liquid strikes, and lets you screen ASND options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ASND stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile4.37% Subdued
- Market cap (M$)14,815
- 52 weeks high-20.04%
- 52 weeks low21.26%
- Analyst recommendationStrong Buy
1.10 - Target price$311.51
38.08% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E17.19
- Future P/E21.68
- EPS (ttm)13.12
- EPS growth next 5 years—
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 24.10 | 1 | 0 | 3.15 | 15.60 | 16.80 | 20.70 | 210.00 | -6.91 | 0.75 | 4.50 | 0.00 | 2.63 | 1 | 34 | 75.90 |
| 40.90 | 74 | 0 | 6.35 | 5.60 | 10.10 | 13.80 | 220.00 | -2.48 | 4.30 | 7.20 | 0.00 | 5.75 | 0 | 229 | 59.10 |
| 58.79 | 91 | 0 | 6.90 | 0.00 | 5.00 | 8.80 | 230.00 | +1.95 | 9.00 | 12.40 | 4.40 | 6.30 | 0 | 195 | 41.21 |
| 74.38 | 182 | 0 | 3.53 | 0.00 | 1.65 | 5.40 | 240.00 | +6.38 | 15.00 | 18.60 | 14.40 | 2.40 | 1 | 257 | 25.62 |
| 85.78 | 1,196 | 1 | 3.50 | 0.00 | — | 3.50 | 250.00 | +10.82 | 23.50 | 26.80 | 24.40 | 0.75 | 4 | 85 | 14.22 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full ASND option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→